Neoantigen Synthetic Long Peptide Vaccines
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neoantigen Synthetic Long Peptide Vaccines, covering 2026-01-15 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors [Phase 1, Phase 2]